Soft Tissue Repair Market Report by Product (Fixation Products, Tissue Patch/Match), Application (Orthopedic Surgery, Breast Reconstruction, Hernia Repair, Skin Repair, Vaginal Sling Repair, Cardiovascular Surgery, and Others), End Use (Hospitals and Clin

Soft Tissue Repair Market Report by Product (Fixation Products, Tissue Patch/Match), Application (Orthopedic Surgery, Breast Reconstruction, Hernia Repair, Skin Repair, Vaginal Sling Repair, Cardiovascular Surgery, and Others), End Use (Hospitals and Clinics, Research and Academic Institutes, and Others), and Region 2024-2032


The global soft tissue repair market size reached US$ 14.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 19.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.8% during 2024-2032.

Soft tissues comprise muscles, tendons, fascia, nerves, fat, ligaments, blood vessels, and synovial membranes that connect, surround, and support other structures and organs of the body. Many physical activities can lead to their damage, which further results in pain, sprains, strains, swelling, bursitis, tendinitis, and contusions. As a result, various remedial interventions are utilized for restoring, repairing, and regenerating soft tissues. For instance, scaffolds made using natural polymers like chitosan, gelatin, and alginate are used as biomaterials for their repair. Besides this, the use of allografts and xenografts is also gaining traction for repairing severe damages around the world.

Soft Tissue Repair Market Trends:

The growing participation of individuals, especially children, in professional sports increases the risk of developing an injury in soft tissues. This, in confluence with the increasing concerns among parents about the physical health of their child, represents one of the primary factors influencing the market growth positively. Its repair helps in faster recovery and improving athletic performance. Apart from this, the growing aging population is catalyzing the demand for biomaterials that have high efficiency and can effectively repair damaged soft tissues in a short time. These biomaterials are also used in a variety of soft tissue procedures, including dural tears, chest wall reconstruction, cardiac and cardiovascular surgery, abdominal wall repair, and pelvic organ prolapse treatment. Furthermore, rising incidences of musculoskeletal disorders is promoting the need for biomedical implants to reorganize the bone and its associated soft tissues. Other factors, such as favorable reimbursement policies, the increasing popularity of medical tourism, and rising investments in research and development (R&D) activities, are anticipated to strengthen the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global soft tissue repair market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end use.

Breakup by Product:
  • Fixation Products
  • Suture
  • Suture Anchors
  • Tissue Patch/Match
  • Biological
  • Synthetic
Breakup by Application:
  • Orthopedic Surgery
  • Breast Reconstruction
  • Hernia Repair
  • Skin Repair
  • Vaginal Sling Repair
  • Cardiovascular Surgery
  • Others
Breakup by End Use:
  • Hospitals and Clinics
  • Research and Academic Institutes
  • Others
Breakup by Region:
  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Arthrex Inc., Becton Dickinson and Company, Baxter International Inc., Cryolife Inc., Integra LifeSciences Corporation, Johnson & Johnson, Medtronic Plc, Organogenesis Inc., Smith & Nephew plc, Stryker Corporation and Terumo Corporation.

Key Questions Answered in This Report

1. How big is the global soft tissue repair market?

2. What is the expected growth rate of the global soft tissue repair market during 2024-2032?

3. What are the key factors driving the global soft tissue repair market?

4. What has been the impact of COVID-19 on the global soft tissue repair market?

5. What is the breakup of the global soft tissue repair market based on the product?

6. What is the breakup of the global soft tissue repair market based on the application?

7. What is the breakup of the global soft tissue repair market based on the end use?

8. What are the key regions in the global soft tissue repair market?

9. Who are the key players/companies in the global soft tissue repair market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Soft Tissue Repair Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Fixation Products
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Suture
6.1.2.2 Suture Anchors
6.1.3 Market Forecast
6.2 Tissue Patch/Match
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Biological
6.2.2.2 Synthetic
6.2.3 Market Forecast
7 Market Breakup by Application
7.1 Orthopedic Surgery
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Breast Reconstruction
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Hernia Repair
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Skin Repair
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Vaginal Sling Repair
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Cardiovascular Surgery
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by End Use
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research and Academic Institutes
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AbbVie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Arthrex Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.3 Becton, Dickinson and Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Baxter International Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Cryolife Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Integra LifeSciences Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Johnson & Johnson
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Medtronic Plc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Organogenesis Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Smith & Nephew plc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Stryker Corporation
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Terumo Corporation
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings